Although our study cannot test this hypothesis, we believe that chronic exposure to excess IL-6 levels in the liver may cause persistent liver damage leading to progressive liver disease, further increasing the risk of HCC and liver-related mortality. Here, IL6 is linked to hepatocellular carcinoma.